Clinical Trial Update: Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

View source ↗

Summary

A completed Duke University clinical trial evaluating novel retinal imaging biomarkers for detecting early Alzheimer's disease and related cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Duke University | Conditions: Mild Cognitive Impairment, Mild to Moderate Cognitive Impairment | Status: COMPLETED